220 related articles for article (PubMed ID: 22169011)
1. Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.
Borsting E; Cheng VP; Glass CK; Vallon V; Cunard R
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F540-51. PubMed ID: 22169011
[TBL] [Abstract][Full Text] [Related]
2. PPARγ agonist-induced fluid retention depends on αENaC expression in connecting tubules.
Fu Y; Gerasimova M; Batz F; Kuczkowski A; Alam Y; Sanders PW; Ronzaud C; Hummler E; Vallon V
Nephron; 2015; 129(1):68-74. PubMed ID: 25531136
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of ENaC activity by rosiglitazone is PPARγ-dependent and correlates with SGK1 expression increase.
Renauld S; Tremblay K; Ait-Benichou S; Simoneau-Roy M; Garneau H; Staub O; Chraïbi A
J Membr Biol; 2010 Aug; 236(3):259-70. PubMed ID: 20740360
[TBL] [Abstract][Full Text] [Related]
4. PPARγ-induced stimulation of amiloride-sensitive sodium current in renal collecting duct principal cells is serum and insulin dependent.
Chraïbi A; Renauld S
Cell Physiol Biochem; 2014; 33(3):581-93. PubMed ID: 24603133
[TBL] [Abstract][Full Text] [Related]
5. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
Orasanu G; Ziouzenkova O; Devchand PR; Nehra V; Hamdy O; Horton ES; Plutzky J
J Am Coll Cardiol; 2008 Sep; 52(10):869-81. PubMed ID: 18755353
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel.
Pavlov TS; Levchenko V; Karpushev AV; Vandewalle A; Staruschenko A
Mol Pharmacol; 2009 Dec; 76(6):1333-40. PubMed ID: 19752200
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinedione-induced fluid retention is independent of collecting duct alphaENaC activity.
Vallon V; Hummler E; Rieg T; Pochynyuk O; Bugaj V; Schroth J; Dechenes G; Rossier B; Cunard R; Stockand J
J Am Soc Nephrol; 2009 Apr; 20(4):721-9. PubMed ID: 19158355
[TBL] [Abstract][Full Text] [Related]
8. Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.
Zhang H; Zhang A; Kohan DE; Nelson RD; Gonzalez FJ; Yang T
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9406-11. PubMed ID: 15956187
[TBL] [Abstract][Full Text] [Related]
9. Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats.
Tiwari S; Blasi ER; Heyen JR; McHarg AD; Ecelbarger CM
Pharmacol Res; 2008 May; 57(5):383-92. PubMed ID: 18468451
[TBL] [Abstract][Full Text] [Related]
10. Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone.
Artunc F; Sandulache D; Nasir O; Boini KM; Friedrich B; Beier N; Dicks E; Pötzsch S; Klingel K; Amann K; Blazer-Yost BL; Scholz W; Risler T; Kuhl D; Lang F
Pflugers Arch; 2008 May; 456(2):425-36. PubMed ID: 18172605
[TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters.
Zhou L; Liu G; Jia Z; Yang KT; Sun Y; Kakizoe Y; Liu M; Zhou S; Chen R; Yang B; Yang T
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1491-7. PubMed ID: 24005472
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.
Higashi Y; Holder K; Delafontaine P
J Biol Chem; 2010 Nov; 285(47):36361-8. PubMed ID: 20843793
[TBL] [Abstract][Full Text] [Related]
13. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption.
Guan Y; Hao C; Cha DR; Rao R; Lu W; Kohan DE; Magnuson MA; Redha R; Zhang Y; Breyer MD
Nat Med; 2005 Aug; 11(8):861-6. PubMed ID: 16007095
[TBL] [Abstract][Full Text] [Related]
15. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
16. Role of the EGF receptor in PPARγ-mediated sodium and water transport in human proximal tubule cells.
Saad S; Zhang J; Yong R; Yaghobian D; Wong MG; Kelly DJ; Chen XM; Pollock CA
Diabetologia; 2013 May; 56(5):1174-82. PubMed ID: 23370527
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats.
Song J; Knepper MA; Hu X; Verbalis JG; Ecelbarger CA
J Pharmacol Exp Ther; 2004 Feb; 308(2):426-33. PubMed ID: 14593089
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
Sommer M; Wolf G
Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.
Schinner S; Krätzner R; Baun D; Dickel C; Blume R; Oetjen E
Br J Pharmacol; 2009 Jul; 157(5):736-45. PubMed ID: 19338578
[TBL] [Abstract][Full Text] [Related]
20. Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
Al-Alem L; Southard RC; Kilgore MW; Curry TE
PLoS One; 2011 Jan; 6(1):e16179. PubMed ID: 21283708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
